Department of Medicine

Clinical Pharmacology

Current Fellows

Click here to meet our Fellowship Alumni


Kimberly Collins, PhD


Dr. Collins' research interest is in the identification of markers of acute kidney injury and the implementation of genetic testing to improve treatments for patients with chronic kidney disease and hypertension.

Tom DeLuca, PhD

Dr. DeLuca’s main project is the creation of a rat model to determine baseline circulating exosomal miRNA kinetics.  In addition, he is also researching that preclinical studies in animals often require frequent and extended blood sampling over time.

Cathy Fulton, DNP, ANP-BC, FNP-BC, RN

Dr. Fulton is currently working to develop clinical decision support related to the pharmacogenomic testing in the INGENIOUS trial (NCT02297126). In addition, she is also analyzing recruitment from the INGENIOUS trial as stratfied by health systems as well as the demographic anlaysis, actionable genotype distribution, drug-drug interactions, proportion of concomitant analgesic therapy in these subjects, provider utilization and adverse events.

Ellen Go, MD

Dr. Go's current research is the effects of mycophenolic acid on endothelial precursor cells and the role and response of endothelial cells in various phases of inflammation to better understand the pathophysiiologic mechanism behind primary systemic vasculitis.  Long-term goal is to discover biomarkers and potential therapies to treat childhood-onset rheumatic disease.

Sri Kanuri, MBBS

Dr. Kanuri's research is to assess miRNA expression profile that is specific to high risk and low risk of QT prolongation following drug administration. This will eventually lead to development of biomarkers and formulation of novel therapeutic interventions for prevention and treatment of cardiac arrhythmias. These methods will be addressed using PK and PD modelling, molecular assessments and translational pharmacology.

Stephanie Liu, PharmD

Dr. Liu completed her Doctor of Pharmacy at the Philadelphia College of Pharmacy. She is a licensed pharmacist in Pennsylvania and Indiana. Her research interests are in clinical pharmacology, pharmacokinetics, and drug disposition. She would like to pursue a career as a clinical pharmacologist in early phase drug development.

JD Podichetty, MS, PhD

Dr. Podichetty has a MS/PhD in Chemical Engineering from Oklahoma State University and received Post-Doctoral training in Physiology from University of Michigan. He is currently working in collaboration with Takeda Pharmaceuticals Inc. on developing models that characterize and predict Central Nervous System (CNS) disease progression using Data Mining and Machine Learning techniques. His other research interests include whole body and population Pharmacokinetics/Pharmacodynamics (PKPD), Deep Learning, and Pharmacogenomics.

Violeta Rodriguez Romero, PhD

Dr. Rodriguez-Romero is a Postdoctoral Fellow working at the Disease and Therapeutic Response Modeling Program located in the Division of Clinical Pharmacology at Indiana University School of Medicine, Indiana Clinical and Translational Sciences Institute. Dr. Rodriguez-Romero has been exploring machine learning techniques to predict diabetic nephropathy using WEKA and CARET package from R. Her interest in Modeling also includes the application of Non-linear mixed effects modeling (NONMEM) to different populations.

Alicia Teagarden, DO

Describing the incidence of post-transplant diabetes mellitus (PTDM) in pediatric hematopoietic cell (HCT) patients and relationship to ST2 levels. Further evaluating the relationship of PTDM in pediatric HCT patients and critical care outcomes. A secondary project is to describe the incidence of persistent inflammatory, immunosuppressed, catabolic syndrome (PICS) in critically ill pediatric patients and evaluating the relationship of PICS with survival and other critical care outcomes.